ADMA Biologics, Inc. (ADMA)
8.24
-0.22
(-2.60%)
USD |
NASDAQ |
May 22, 16:00
8.26
+0.02
(+0.24%)
After-Hours: 20:00
ADMA Biologics Total Assets (Quarterly) : 665.18M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 1.148B |
| Inovio Pharmaceuticals, Inc. | 49.78M |
| Palisade Bio, Inc. | 133.32M |
| ACADIA Pharmaceuticals, Inc. | 1.605B |
| AnaptysBio, Inc. | 329.68M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 274.86M |
| Shareholders Equity (Quarterly) | 390.32M |
| Debt to Equity Ratio | 0.5237 |
| Current Ratio | 6.951 |
| Net Debt Paydown Yield | -1.17% |